Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wagner Dimas is a specialized technology and contract manufacturing organization (CMO) that provides automated solutions for the cannabis industry. The company is best known for its proprietary high-volume pre-roll manufacturing technology, which allows for the mass production of cannabis cigarettes with high precision and consistency. By leveraging advanced automation, Wagner Dimas enables licensed producers to scale their operations while maintaining strict quality control standards. The company was acquired by Humble & Fume in 2021, further expanding its reach across the North American cannabis market. Its business model focuses on B2B partnerships, providing manufacturing-as-a-service to established and emerging cannabis brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wagner Dimas.